Compound ID | 1252

Update compound information

RX-P2382

Class: Pyrrolocytosine

Spectrum of activity: Gram-positive  &  Gram-negative
Details of activity: Activity against multidrug-resistant ESKAPE pathogens, known to cause complicated urinary tract, skin, and lung infections, as well as sepsis.
Institute where first reported: Melinta Therapeutics, Inc
Year first mentioned: 2018
Highest developmental phase: Preclinical
Development status: Active
External links:
Citations:
  • https://www.jmilabs.com/data/posters/ASM-ESCMID-2018-RX-P2382-ribosome-inhibitor.pdf
  • https://www.escmid.org/escmid_publications/escmid_elibrary/?q=RX-P2382+&id=2173&L=0&x=0&y=0

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.